292 related articles for article (PubMed ID: 8634009)
1. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
[TBL] [Abstract][Full Text] [Related]
2. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
[TBL] [Abstract][Full Text] [Related]
5. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
[TBL] [Abstract][Full Text] [Related]
6. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
Tenback DE; van Harten PN; Slooff CJ; van Os J;
Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
[TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E
Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
9. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
Morgenstern H; Glazer WM
Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia in 2 patients treated with ziprasidone.
Ananth J; Burgoyne KS; Niz D; Smith M
J Psychiatry Neurosci; 2004 Nov; 29(6):467-9. PubMed ID: 15644988
[TBL] [Abstract][Full Text] [Related]
13. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
van Harten PN; Hoek HW; Matroos GE; van Os J
J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
Yuen O; Caligiuri MP; Williams R; Dickson RA
Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
[TBL] [Abstract][Full Text] [Related]
16. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
[TBL] [Abstract][Full Text] [Related]
17. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
18. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Tenback DE; van Harten PN; Slooff CJ; van Os J
Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
[TBL] [Abstract][Full Text] [Related]
19. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
Jeste DV; Caligiuri MP; Paulsen JS; Heaton RK; Lacro JP; Harris MJ; Bailey A; Fell RL; McAdams LA
Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127
[TBL] [Abstract][Full Text] [Related]
20. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
